Clinical trials

  • IXEKIZUMAB for Psoriatic arthritis
  • AXATILIMAB for Chronic graft-versus-host disease
  • Adeno-associated virus serotype 2 encoding soluble CD59 for Geographic atrophy secondary to age-related macular degeneration
  • Savolitinib for Papillary renal cell carcinoma (MET-driven, unresectable, locally advanced or metastatic)
  • Remibrutinib for Chronic spontaneous urticaria
  • LINAPRAZAN GLURATE for Erosive esophagitis due to gastroesophageal reflux disease (GERD)
  • ANSELAMIMAB for AL amyloidosis | Cardiac AL amyloidosis (Mayo stage IIIb)
  • Pelacarsen for Calcific aortic valve stenosis
  • Budesonide for Episodic expiratory wheezing
  • RIBOCICLIB for Hormone receptor-positive HER2-negative early breast cancer
  • ROZANOLIXIZUMAB for Generalized myasthenia gravis
  • Mirabegron for Healthy volunteers